Taking oral caffeine supplements may significantly reduce fatigue and improve quality of life and mood in people with MS, trial results show.

A trial found six weeks of yoga improved sleep quality and reduced fatigue in people with MS, suggesting its use as a ...

September and October 2025 have proven busy for multiple sclerosis (MS) professionals, as many gathered at three major conferences to discuss trials in the indication that could alter the current ...

Quantum BioPharma Ltd. has successfully completed its Phase 1 clinical trial of Lucid-21-302, also known as Lucid-MS, a novel compound aimed at treating multiple sclerosis (MS). A safety review ...

AUTOIMMUNE DISEASE WITH NO CURE, BUT UNMC IS AT THE FOREFRONT OF FINDING ONE. A GROUNDBREAKING CLINICAL TRIAL IS DOING SOMETHING NO ONE ELSE EVER HAS. IT APPEARS TO BE WORKING. KETV NEWSWATCH SEVEN’S ...

Roche’s Phase III trial examining higher doses of intravenous (IV) Ocrevus (ocrelizumab) as a means of slowing disability progression in patients living with relapsing multiple sclerosis (MS) has not ...

Long-term CNM-Au8 treatment demonstrated significant and clinically meaningful improvement of vision as measured by low contrast letter acuity (LCLA), an assessment of visual function in people living ...

Multiple sclerosis (MS) could be "on the brink of a new class of treatment" after early trial results suggest two drugs may repair damage caused by the condition. A study led by the University of ...

Three investigators and their teams have received funding for clinical trial development projects as part of the International Progressive MS Alliance’s Experimental Medicine Trial Awards. These ...